The January megadeals included transactions in the energy, financials, pharmaceuticals and materials sectors, signaling a ...

Investing.com -- S&P Global (NYSE: SPGI) Ratings has assigned an 'AAA' issue-level rating to Johnson & Johnson (NYSE: JNJ )'s newly offered senior unsecured notes, which are to be issued in multiple ...

Highlights,Savant Capital LLC significantly decreased its holdings in Intra-Cellular Therapies in the fourth quarter.,Various financial firms have adjusted their stakes, with some increasing positions ...

Axsome Therapeutics reports strong Q4 2024 revenues, driven by increased sales of Auvelity and Sunosi. Anticipated milestones and FDA approval for Symbravo make AXSM a top pick for 2025.

StockNews.com started coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the ...

We recently compiled a list of the 13 Best Forever Stocks to Buy Right Now. In this article, we are going to take a look at ...

In a remarkable display of market confidence, Intra-Cellular Therapies Inc. (NASDAQ:ITCI) stock has reached an all-time high, touching a price level of $128.01. According to InvestingPro data, the ...

Discover how major indices remain resilient amidst volatility and explore value opportunities in down-cap stocks.